Genenta Science (ADR) (GNTA)
Develops tumor-targeted gene therapy and staged Italian defense and aerospace investments.
$0.6877
vs last close−0.02 (−2.32%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.76% | 720.7K ADS | |
|---|---|---|---|
| 9 holders · as of Jun 30, 2026 | |||
| Insiders | 12.03% | 2.30M ADS | |
| 1 holder · as of Jan 27, 2026 | |||
| Other | 84.21% | 16.12M ADS | |
| remainder | |||
19.15M ADS as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
13F, as of Jun 30, 2026
9 holders · 720.7K shares · 2 new positions · 3 increased · 3 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Eurizon Capital SGR S.P.A. | 360.0K | 1.88% | 0 | Jul 29, 2026 |
| Allianz SE | 234.1K | 1.22% | 0 | Aug 10, 2026 |
| Smartharvest Portfolios, LLC | 43.9K | 0.23% | −90.6K | Aug 4, 2026 |
| Virtu Financial LLC | 36.9K | 0.19% | +36.9Knew | Aug 13, 2026 |
| Simplicity Wealth,LLC | 18.6K | 0.10% | +6.4K | Aug 6, 2026 |
| Ground Swell Capital, LLC | 14.4K | 0.08% | +14.4Knew | Aug 5, 2026 |
| Gamma Investing LLC | 9.9K | 0.05% | −4.4K | Jul 7, 2026 |
| UBS Group AG | 3.0K | 0.02% | −80 | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Fidim S.p.A.incl. Vittorio Avogadro di Collobiano, Gaudenzio Roveda +8 more | 23.00% | 5.43M | 13D | May 5, 2026 |
| Pierluigi Paracchi | 9.80% | 2.30M | 13G | Jan 27, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.